Skip to site menu Skip to page content

Podcast: An emerging biotech’s guide to the CRO search

Centessa’s Scott Sawicki details how biotechs looking to transition to clinical work should look at CROs.

Frankie Fattorini November 12 2026

For a small biotech looking to make the jump into running its first clinical trial, the right CRO can be crucial to success.

The question of what early-stage drug developers should look for in a vendor was answered by Scott Sawicki, senior director of strategic sourcing and vendor management at Centessa Pharmaceuticals. Now under the Eli Lilly umbrella since Centessa’s acquisition in June 2026, Sawicki brought his experience from big pharma and innovative biotech, as well as working within CROs, to discuss the opportunities and pitfalls companies face in outsourcing clinical work for the first time.

Sawicki explored these topics in a Q&A session with Clinical Trials Arena reporter Frankie Fattorini at the 2026 Outsourcing in Clinical Trials New England conference, held 27–28 October in Boston, Massachusetts.

You can listen to more podcasts from the GlobalData Media Healthcare team here. GlobalData is the parent company of Clinical Trials Arena.

Uncover your next opportunity with expert reports

Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.

Newsletters by sectors

close

Sign up to the newsletter: In Brief

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close